OOIR: Observatory of International Research

Papers

(The median citation count of Medical Oncology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Oncotype DX testing does not affect clinical practice in stage IIa colon cancer	48
The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer	30
The immunomodulatory effects of Candida albicans isolated from the normal gastrointestinal microbiome of the elderly on colorectal cancer	27
COVID-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients	27
The role of inflammatory indices in the outcome of COVID-19 cancer patients	26
How to ensure uninterrupted treatment of radiotherapy patients during delta variants of SARS-CoV-2 virus epidemic: the latest experience from Xi’an, China	22
Identification of the role of mono-ADP-ribosylation in colorectal cancer by integrated transcriptome analysis	21
Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapy	20
Enhancement of Apo2L/TRAIL signaling pathway receptors by the activation of Klotho gene with CRISPR/Cas9 in Caco-2 colon cancer cells	19
Notch signaling in oral pre-cancer and oral cancer	19
DNMT1 and miRNAs: possible epigenetics footprints in electromagnetic fields utilization in oncology	19
The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer	18
The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 si	17
sABLATE: a simplified ABLATE score for prediction of complications and outcome in percutaneous thermal ablation of renal lesions	15
Regulatory mechanisms of heme regulatory protein BACH1: a potential therapeutic target for cancer	15
Mefenamic acid as a promising therapeutic medicine against colon cancer in tumor-bearing mice	15
Innovation in cancer therapeutics and regulatory perspectives	15
AFP peptide (AFPep) as a potential growth factor for prostate cancer	14
A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways	14
PARP1-modulated chromatin remodeling is a new target for cancer treatment	14
Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model	14
Combined evaluation of proliferation and apoptosis to calculate IC50 of VPA-induced PANC-1 cells and assessing its effect on the Wnt signaling pathway	14
Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies	13
DNA methylation marker to estimate ovarian cancer cell fraction	13
Interferon regulatory factor-1 regulates cisplatin-induced apoptosis and autophagy in A549 lung cancer cells	13

Direct oral anticoagulants in cancer patients: which help from the specialist hemostasis and thrombosis laboratory?	13
In silico bioinformatics analysis for identification of differentially expressed genes and therapeutic drug molecules in Glucocorticoid-resistant Multiple myeloma	13
The combination therapy of Everolimus and anti-PD-1 improves the antitumor effect by regulating CD8+ T cells in bladder cancer	12
Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells	12
Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention	12
AICAR enhances the cytotoxicity of PFKFB3 inhibitor in an AMPK signaling-independent manner in colorectal cancer cells	12
Resveratrol triggers anti-proliferative and apoptotic effects in FLT3-ITD-positive acute myeloid leukemia cells via inhibiting ceramide catabolism enzymes	12
ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer	12
Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial–mesenchymal transition in prostate cancer	12
Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy	12
Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma	11
Transcription factors linked to the molecular signatures in the development of hepatocellular carcinoma on a cirrhotic background	11
HELZ2 promotes K63-linked polyubiquitination of c-Myc to induce retinoblastoma tumorigenesis	11
Who should be treated with pembrolizumab in addition to standard of care in advanced cervical cancer?	11
The effects of chemotherapeutic drugs on PD-L1 gene expression in breast cancer cell lines	11
Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors	11
Bioymifi, a novel mimetic of TNF-related apoptosis-induced ligand (TRAIL), stimulates eryptosis	11
Glioblastoma recurrent cells switch between ATM and ATR pathway as an alternative strategy to survive radiation stress	10
Isolation and characterization of a novel GRP78-specific single-chain variable fragment (scFv) using ribosome display method	10
RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression	9
WAC, a novel GBM tumor suppressor, induces GBM cell apoptosis and promotes autophagy	9
SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling	9
Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling	9
Novel molecules as the emerging trends in cancer treatment: an update	9
Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer	8
ERCC6L is a biomarker and therapeutic target for non–small cell lung adenocarcinoma	8
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radio	8
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives	8
Effects of electroporation on anticancer activity of 5-FU and newly synthesized zinc(II) complex in chemotherapy-resistance human brain tumor cells	8
Cancer induced bone pain: current management and future perspectives	8
Detection of human papillomavirus infection in oral cancers reported at dental facility: assessing the utility of FFPE tissues	8
Blue light induces ROS mediated apoptosis and degradation of AML1-ETO oncoprotein in Kasumi-1 cells	8
Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs	8